These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28411922)

  • 21. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
    Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
    Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
    Bani-Hani AH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML
    J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic and partial nephrectomy.
    Novick AC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6322S-7S. PubMed ID: 15448025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of renal-sparing surgery for renal cell carcinoma.
    Novick AC
    Semin Urol; 1992 Feb; 10(1):12-5. PubMed ID: 1565898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
    Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
    Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
    Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
    Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a single institution study with > or =3 years of follow-up.
    Bromwich E; Wedderburn A
    BJU Int; 2008 Jun; 101(12):1595-6. PubMed ID: 18489406
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
    Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
    Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic metastasis from renal cell carcinoma 16 years after nephrectomy: a case report and review of the literature.
    David AW; Samuel R; Eapen A; Vyas F; Joseph P; Sitaram V
    Trop Gastroenterol; 2006; 27(4):175-6. PubMed ID: 17542297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
    Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
    BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
    Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive surgery for renal cell carcinoma.
    Ghoneim IA; Fergany AF
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):989-97. PubMed ID: 19589037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.